Software-only products providing free-standing treatment represent a key healthcare opportunity for incumbents.
Three CEOs discuss why digital treatments are on the cusp of becoming mainstream and share their five-year outlooks.
Five workstreams to help leaders adopt a new organizational approach.
It's time to get comfortable with being uncomfortable.
Innovator-Led Innovations May Soon Come True
Healthcare leaders demand disruption, but who will spark big change first?
A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.
Seeing a return on investment in pharma marketing means understanding what happens to every dollar.
Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.
Health and wellness is shaping consumerism’s future. As potentially industry-shaking partnerships evolve, who’s best positioned to conquer the market?
While many leading industries are adapting well to disruption, healthcare is just now catching up. Here's more from an executive session discussion at the recent Oliver Wyman Health Innovation Summit.